Cite

1. Amir RE, Van dV, I, Wan M, Tran CQ, Francke U, Zoghbi HY (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.Search in Google Scholar

2. Hagberg B, Aicardi J, Dias K, Ramos O (1983). A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol 14: 471-479.Search in Google Scholar

3. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, et al. (2010). Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68: 944-950.Search in Google Scholar

4. Zappella M (1992). The Rett girls with preserved speech. Brain Dev 14: 98-101.Search in Google Scholar

5. Rolando S (1985). Rett syndrome: report of eight cases. Brain Dev 7: 290-296.Search in Google Scholar

6. Hanefeld F (1985). The clinical pattern of the Rett syndrome. Brain Dev 7: 320-325.Search in Google Scholar

7. Shahbazian MD, Zoghbi HY (2002). Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet 71: 1259-1272.Search in Google Scholar

8. De BC, Zappella M, Hayek G, Meloni I, Vitelli F, Bruttini M, et al. (2000). Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet 8: 325-330.Search in Google Scholar

9. Zappella M, Meloni I, Longo I, Canitano R, Hayek G, Rosaia L, et al. (2003). Study of MECP2 gene in Rett syndrome variants and autistic girls. Am J Med Genet B Neuropsychiatr Genet 119B: 102-107.Search in Google Scholar

10. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, et al. (1992). Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69: 905-914.Search in Google Scholar

11. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, et al. (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389.Search in Google Scholar

12. Nan X, Tate P, Li E, Bird A (1996). DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 16: 414-421.Search in Google Scholar

13. Chandler SP, Guschin D, Landsberger N, Wolffe AP (1999). The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38: 7008-7018.Search in Google Scholar

14. Ballestar E, Yusufzai TM, Wolffe AP (2000). Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry 39: 7100-7106.Search in Google Scholar

15. Yusufzai TM, Wolffe AP (2000). Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 28: 4172-4179.Search in Google Scholar

16. NCBI. http://www.ncbi.nlm.nih.gov/gene/4204.20137-15-2013. Ref Type: Electronic CitationSearch in Google Scholar

17. HUGO. http://www.genenames.org/data/hgnc_data.php?hgnc_id=6990 . 2011. 7-15-2013. Ref Type: Electronic CitationSearch in Google Scholar

18. USCS genome browser. http://genome.ucsc.edu/cgibin/hgBlat?command=start . 2009. 7-15-2013. Ref Type: Electronic CitationSearch in Google Scholar

19. USCSdbSNP(137). http://genome.ucsc.edu/cgibin/hgTrackUi?hgsid=342271035&c=chrX&g=snp137- Common . 2012. Ref Type: Electronic CitationSearch in Google Scholar

20. Ohki I, Shimotake N, Fujita N, Nakao M, Shirakawa M (1999). Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1. EMBO J 18: 6653-6661.Search in Google Scholar

21. Goffin D, Allen M, Zhang L, Amorim M, Wang IT, Reyes AR, et al. (2012). Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci 15: 274-283.Search in Google Scholar

22. Obata K, Matsuishi T, Yamashita Y, Fukuda T, Kuwajima K, Horiuchi I, et al. (2000). Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome. J Med Genet 37: 608-610.Search in Google Scholar

23. Baker SA, Chen L, Wilkins AD, Yu P, Lichtarge O, Zoghbi HY (2013). An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152: 984-996.Search in Google Scholar

24. Klose RJ, Sarraf SA, Schmiedeberg L, McDermott SM, Stancheva I, Bird AP (2005). DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 19: 667-678.Search in Google Scholar

25. Nan X, Campoy FJ, Bird A (1997). MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471-481.Search in Google Scholar

26. Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, et al. (2000). Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 9: 1119-1129.Search in Google Scholar

27. Kammoun F, de RN, Boespflug-Tanguy O, Vallee L, Seng R, Tardieu M, et al. (2004). Screening of MECP2 coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases. J Med Genet 41: e85.Search in Google Scholar

28. Ravn K, Nielsen JB, Skjeldal OH, Kerr A, Hulten M, Schwartz M (2005). Large genomic rearrangements in MECP2. Hum Mutat 25: 324. Search in Google Scholar

ISSN:
2284-5623
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology